Glucosamine Chondroitin in 2026: Current Evidence, Guideline Stance, and Practical Facts for U.S. Readers
Glucosamine chondroitin remains widely sold across the United States as a joint-support supplement, yet September 2026 brought a clear medical update. The American College of Rheumatology released its 2026 recommendations for osteoarthritis of the knee, hip, and hand. The panel issued a strong recommendation against glucosamine, chondroitin, and combination products for these joints. The summary … Read more